Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare delivery through innovative solutions. Utilizing advanced technologies, including artificial intelligence and data analytics, the company significantly improves diagnostic accuracy, treatment efficiency, and patient management. With a robust commitment to research and development, Haoxi is well-positioned to capitalize on emerging trends in healthcare technology, presenting considerable growth opportunities for institutional investors looking to engage in this dynamic market.
| Revenue (TTM) | $42.68M |
| Gross Profit (TTM) | $2.04M |
| EBITDA | $-7.05M |
| Operating Margin | -16.80% |
| Return on Equity | -16.00% |
| Return on Assets | -22.10% |
| Revenue/Share (TTM) | $1202.80 |
| Book Value | $0.27 |
| Price-to-Book | 0.15 |
| Price-to-Sales (TTM) | 0.06 |
| EV/Revenue | 0.895 |
| EV/EBITDA | 13.53 |
| Quarterly Earnings Growth (YoY) | 172.70% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | $1.84M |
| Float | 395,200 |
| % Insiders | 0.18% |
| % Institutions | 0.01% |
Volatility is currently expanding